Fractional shares
Get dividend payments
89bio Inc (ETNB) is a publicly traded biotechnology business based in the US which employs around 50 staff. 89bio is listed on the NASDAQ and traded in US dollars. Its current price of $8.18 is 8.1% up on its price a month ago ($7.57).
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Buying shares in just one company is generally considered a riskier bet than investing in a range of investments - AKA a "diversified portfolio". Experts generally recommend holding a mix of investments in specific assets and funds. Funds are ready-made portfolios of multiple companies' shares (potentially including 89bio), and the idea is that drops in the value of one constituent company's share price might be offset by rises in others.
89bio is a major part of the NASDAQ, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).
Review technicals and fundamentals to help you determine if now's a good time for you to invest.
View 89bio's price performance, share price volatility, historical data and technicals.
Historical closes compared with the last close of $8.18
1 week (2024-10-22) | -0.37% |
---|---|
1 month (2024-09-29) | 8.06% |
3 months (2024-07-29) | -11.47% |
6 months (2024-04-29) | -0.97% |
1 year (2023-10-29) | 16.69% |
2 years (2022-10-29) | -6.41% |
3 years (2021-10-29) | -53.10% |
5 years (2019-10-29) |
The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the 89bio P/E ratio, PEG ratio and EBITDA.
89bio's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 0x. In other words, 89bio's shares trade at around 0x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the United States stock markets on average as of November 09, 2023 (20.44). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
89bio's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give None. Higher PEG ratios such as this can be interpreted as meaning the shares offer worse value given the current rate of growth.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into 89bio's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Find out how to spot some of the best day trading stocks available in the UK and abroad, along with tips for managing your investment portfolio on a day-to-day basis.
We’ve tested, analysed and scored trading platforms to find the 10 best trading platforms in the UK, who they’re best for and the pros and cons.
Find out what Web3 is all about, including pros and cons of Web3 and how you can invest.
Some trading apps and platforms now offer competitive interest rates on uninvested cash.
We’ve tested, analysed and scored trading apps to find the 10 best trading apps in the UK, who they’re best for and the pros and cons.
We’ve reviewed the best stocks and shares ISA accounts in the UK, explaining who they might suit and what the benefits and drawbacks are.
Learn how to invest in the S&P 500 from the UK and discover some of the best S&P 500 index funds and where you can invest in them.
Find out how you can invest in Nasdaq and compare a range of leading brokers which can let you invest in US stocks cheaply and quickly.
Ever wondered how to buy shares in AT&T? We explain how and compare a range of providers that can give you access to many brands, including AT&T.
We explain how to buy shares in Howden Joinery, explaining the costs and fees you could come up against. We also have a checklist for anyone looking to invest in a company.